ROCKET PHARMACEUTICALS, INC.
Developing LV/AAV gene therapies for rare genetic bone marrow and cardiovascular diseases.
RCKT | NDAQ
Overview
Corporate Details
- ISIN(s):
- US77313F1066
- LEI:
- Country:
- United States of America
- Address:
- 350 FIFTH AVENUE, 10118 NEW YORK
- Website:
- https://www.rocketpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage clinical biopharmaceutical company focused on developing gene therapies for rare and devastating diseases. The company's mission is to provide cures by correcting the root cause of genetic disorders. It employs a multi-platform approach, utilizing both ex vivo lentiviral (LV) and in vivo adeno-associated viral (AAV) technologies to advance its pipeline. Rocket's therapeutic programs target genetic bone marrow-derived and cardiovascular diseases with high unmet medical needs, aiming to deliver transformative treatments to patients and their families.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ROCKET PHARMACEUTICALS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ROCKET PHARMACEUTICALS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ROCKET PHARMACEUTICALS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
